Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-113 |
Sentence |
denotes |
Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease. |
T2 |
114-125 |
Sentence |
denotes |
UNLABELLED: |
T3 |
126-252 |
Sentence |
denotes |
Chronic pulsatile levodopa therapy for Parkinson's disease (PD) leads to the development of motor fluctuations and dyskinesia. |
T4 |
253-370 |
Sentence |
denotes |
We studied the prevalence and predictors of levodopa-induced dyskinesia among multiethnic Malaysian patients with PD. |
T5 |
371-379 |
Sentence |
denotes |
METHODS: |
T6 |
380-498 |
Sentence |
denotes |
This is a cross-sectional study involving 95 patients with PD on uninterrupted levodopa therapy for at least 6 months. |
T7 |
499-548 |
Sentence |
denotes |
The instrument used was the UPDRS questionnaires. |
T8 |
549-642 |
Sentence |
denotes |
The predictors of dyskinesia were determined using multivariate logistic regression analysis. |
T9 |
643-651 |
Sentence |
denotes |
RESULTS: |
T10 |
652-686 |
Sentence |
denotes |
The mean age was 65.6 ± 8.5 years. |
T11 |
687-727 |
Sentence |
denotes |
The mean onset age was 58.5 ± 9.8 years. |
T12 |
728-772 |
Sentence |
denotes |
The median disease duration was 6 (7) years. |
T13 |
773-852 |
Sentence |
denotes |
Dyskinesia was present in 44% (n = 42) with median levodopa therapy of 3 years. |
T14 |
853-932 |
Sentence |
denotes |
There were 64.3% Chinese, 31% Malays, and 3.7% Indians and other ethnic groups. |
T15 |
933-1006 |
Sentence |
denotes |
Eighty-one percent of patients with dyskinesia had clinical fluctuations. |
T16 |
1007-1277 |
Sentence |
denotes |
Patients with dyskinesia had lower onset age ( p < 0.001), longer duration of levodopa therapy ( p < 0.001), longer disease duration ( p < 0.001), higher total daily levodopa dose ( p < 0.001), and higher total UPDRS scores ( p = 0.005) than patients without dyskinesia. |
T17 |
1278-1401 |
Sentence |
denotes |
The three significant predictors of dyskinesia were duration of levodopa therapy, onset age, and total daily levodopa dose. |
T18 |
1402-1414 |
Sentence |
denotes |
CONCLUSIONS: |
T19 |
1415-1485 |
Sentence |
denotes |
The prevalence of levodopa-induced dyskinesia in our patients was 44%. |
T20 |
1486-1594 |
Sentence |
denotes |
The most significant predictors were duration of levodopa therapy, total daily levodopa dose, and onset age. |